These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 9022022

  • 1. Overexpression of mitogen-activated protein kinase kinase kinase reversed cAMP inhibition of NF-kappaB in T cells.
    Ho HY, Lee HH, Lai MZ.
    Eur J Immunol; 1997 Jan; 27(1):222-6. PubMed ID: 9022022
    [Abstract] [Full Text] [Related]

  • 2. Lead activates nuclear transcription factor-kappaB, activator protein-1, and amino-terminal c-Jun kinase in pheochromocytoma cells.
    Ramesh GT, Manna SK, Aggarwal BB, Jadhav AL.
    Toxicol Appl Pharmacol; 1999 Mar 15; 155(3):280-6. PubMed ID: 10079214
    [Abstract] [Full Text] [Related]

  • 3. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 4. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.
    Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018
    [Abstract] [Full Text] [Related]

  • 5. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
    Cianferoni A, Massaad M, Feske S, de la Fuente MA, Gallego L, Ramesh N, Geha RS.
    J Allergy Clin Immunol; 2005 Dec 28; 116(6):1364-71. PubMed ID: 16337472
    [Abstract] [Full Text] [Related]

  • 6. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.
    Mol Carcinog; 2006 Jan 28; 45(1):26-37. PubMed ID: 16267831
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 8. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation.
    Song YS, Park HJ, Kim SY, Lee SH, Yoo HS, Lee HS, Lee MK, Oh KW, Kang SK, Lee SE, Hong JT.
    Neurosci Res; 2004 May 01; 49(1):69-80. PubMed ID: 15099705
    [Abstract] [Full Text] [Related]

  • 9. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
    Jimenez JL, Punzón C, Navarro J, Muñoz-Fernández MA, Fresno M.
    J Pharmacol Exp Ther; 2001 Nov 01; 299(2):753-9. PubMed ID: 11602691
    [Abstract] [Full Text] [Related]

  • 10. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.
    Mol Pharmacol; 2010 Jan 01; 77(1):17-25. PubMed ID: 19828731
    [Abstract] [Full Text] [Related]

  • 11. MAP kinase-dependent, NF-kappaB-independent regulation of inhibitor of apoptosis protein genes by TNF-alpha.
    Furusu A, Nakayama K, Xu Q, Konta T, Kitamura M.
    J Cell Physiol; 2007 Mar 01; 210(3):703-10. PubMed ID: 17133355
    [Abstract] [Full Text] [Related]

  • 12. Extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells.
    Koh YH, Tamizhselvi R, Bhatia M.
    J Pharmacol Exp Ther; 2010 Mar 01; 332(3):940-8. PubMed ID: 20007404
    [Abstract] [Full Text] [Related]

  • 13. gp160 of HIV or anti-CD4 monoclonal antibody ligation of CD4 induces inhibition of JNK and ERK-2 activities in human peripheral CD4+ T lymphocytes.
    Jabado N, Pallier A, Jauliac S, Fischer A, Hivroz C.
    Eur J Immunol; 1997 Feb 01; 27(2):397-404. PubMed ID: 9045910
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor kappaB signaling.
    Rakitina TV, Vasilevskaya IA, O'Dwyer PJ.
    Cancer Res; 2003 Dec 15; 63(24):8600-5. PubMed ID: 14695170
    [Abstract] [Full Text] [Related]

  • 17. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C, Patriotis C, Tsichlis PN.
    Oncogene; 1998 Nov 19; 17(20):2609-18. PubMed ID: 9840924
    [Abstract] [Full Text] [Related]

  • 18. A schizont-derived protein, TpSCOP, is involved in the activation of NF-kappaB in Theileria parva-infected lymphocytes.
    Hayashida K, Hattori M, Nakao R, Tanaka Y, Kim JY, Inoue N, Nene V, Sugimoto C.
    Mol Biochem Parasitol; 2010 Nov 19; 174(1):8-17. PubMed ID: 20540970
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways.
    Sancho R, Macho A, de La Vega L, Calzado MA, Fiebich BL, Appendino G, Muñoz E.
    J Immunol; 2004 Feb 15; 172(4):2341-51. PubMed ID: 14764703
    [Abstract] [Full Text] [Related]

  • 20. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
    Salmeron A, Ahmad TB, Carlile GW, Pappin D, Narsimhan RP, Ley SC.
    EMBO J; 1996 Feb 15; 15(4):817-26. PubMed ID: 8631303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.